| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |